Mangalam Drugs & Organics Q3 Results

  • BSE: 532637
  • NSE: MANGALAM
  • ISIN: INE584F01014
  • Sector: Biotechnology & Drugs
BSE
105.85-1.05 (-0.98%)
Volume2.28 K
Updated: Mon 25 Nov, 2024 | 15:28:14
NSE
106.021.00 (0.95%)
Volume15.90 K
Updated: Mon 25 Nov, 2024 | 15:43:33
Today: 103.00
108.75
52-Wk: 85.16
144.65

Q3 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Mangalam Drugs & Organics Q3 Results

    *All figures in crores except per share values
    Fiscal PeriodDec 23Sep 23QoQ CompDec 22YoY Comp
    Total Revenue 97.3481.56-%63.33-%
    Selling/ General/ Admin Expenses Total 8.9710.11-%9.43-%
    Depreciation/ Amortization 3.633.74-%2.88-%
    Other Operating Expenses Total 12.1218.55-%9.15-%
    Total Operating Expense 93.9983.12-%59.74-%
    Operating Income 3.35-1.56-%3.59-%
    Net Income Before Taxes 0.04-4.76-%0.50-%
    Net Income 0.50-3.56-%0.43-%
    Diluted Normalized EPS 0.31-2.26-%0.27-%

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe
        HomeMarketsPremiumInstant LoanMint Shorts